Outcome of Treatment for Congenital Toxoplasmosis, 1981-2004: The National Collaborative Chicago-Based, Congenital Toxoplasmosis Study

McLeod, Rima; M. Boyer, K.; Karrison, Theodore; Kasza, Kristen; N. Swisher, Charles; Roizen, Nancy; Jalbrzikowski, Jessica; Remington, J.; Heydemann, Peter; Gwendolyn Noble, A.; B. Mets, M.; Holfels, Ellen; Withers, Shawn; Latkany, Paul; Meier, Petra; Study Group, Toxoplasmosis

doi:10.1086/501360

Public

Outcome of Treatment for Congenital Toxoplasmosis, 1981-2004: The National Collaborative Chicago-Based, Congenital Toxoplasmosis Study

Published in Clinical Infectious Diseases • Apr 18, 2006

Authors:

Rima McLeod

K. M. Boyer

Theodore Karrison

Abstract

BACKGROUND: Without treatment, congenital toxoplasmosis has recurrent, recrudescent, adverse outcomes. Long-term follow-up of infants with congenital toxoplasmosis treated throughout their first year of life with pyrimethamine and sulfadiazine has not been reported. METHODS: Between 1981 and 2004, o...

View

Paywalled

Subject

Medicine

Pyrimethamine

Sulfadiazine

Generate AI Take for this paper

Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.

Subject

Generate AI Take for this paper

Discussions